Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott R Plotkin

Showing results (81-90 of 201) with videos related to

Pageof 21
Sort By:
American Journal of Medical Genetics. Part A|February 18, 2017
First report of factors associated with satisfaction in patients with neurofibromatosisEric Riklin, Mojtaba Talaei-Khoei, Vanessa L Merker, et al.
Clinical Nuclear Medicine|October 25, 2013
Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusionTrinity Urban, Ruth Lim, Vanessa L Merker, et al.
Neurology|July 11, 2018
Considerations for development of therapies for cutaneous neurofibromaSharad K Verma, Vincent M Riccardi, Scott R Plotkin, et al.
AJR. American Journal of Roentgenology|September 22, 2007
Value of PET in the assessment of patients with neurofibromatosis type 1Miriam A Bredella, Martin Torriani, Francis Hornicek, et al.
The Oncologist|April 20, 2022
Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer CareKelly E Irwin, Naomi Ko, Elizabeth P Walsh, et al.
Cancers|June 19, 2024
Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related SchwannomatosisSimeng Lu, Zhenzhen Yin, Jie Chen, et al.
Journal of Neuro-Oncology|November 10, 2017
Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTTVanessa L Merker, Sarah McDannold, Eric Riklin, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 13, 2018
Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2Victoria Huang, Amanda L Bergner, Chris Halpin, et al.
Molecular and Cellular Biology|May 20, 2009
NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growthMarianne F James, Sangyeul Han, Carolyn Polizzano, et al.
Experimental Neurology|September 16, 2017
Anti-VEGF treatment improves neurological function in tumors of the nervous systemNa Zhang, Jie Chen, Gino B Ferraro, et al.
Pageof 21

Showing results (81-90 of 201) with videos related to

Sort By:
Pageof 21
American Journal of Medical Genetics. Part A|February 18, 2017
First report of factors associated with satisfaction in patients with neurofibromatosisEric Riklin, Mojtaba Talaei-Khoei, Vanessa L Merker, et al.
Clinical Nuclear Medicine|October 25, 2013
Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusionTrinity Urban, Ruth Lim, Vanessa L Merker, et al.
Neurology|July 11, 2018
Considerations for development of therapies for cutaneous neurofibromaSharad K Verma, Vincent M Riccardi, Scott R Plotkin, et al.
AJR. American Journal of Roentgenology|September 22, 2007
Value of PET in the assessment of patients with neurofibromatosis type 1Miriam A Bredella, Martin Torriani, Francis Hornicek, et al.
The Oncologist|April 20, 2022
Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer CareKelly E Irwin, Naomi Ko, Elizabeth P Walsh, et al.
Cancers|June 19, 2024
Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related SchwannomatosisSimeng Lu, Zhenzhen Yin, Jie Chen, et al.
Journal of Neuro-Oncology|November 10, 2017
Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTTVanessa L Merker, Sarah McDannold, Eric Riklin, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 13, 2018
Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2Victoria Huang, Amanda L Bergner, Chris Halpin, et al.
Molecular and Cellular Biology|May 20, 2009
NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growthMarianne F James, Sangyeul Han, Carolyn Polizzano, et al.
Experimental Neurology|September 16, 2017
Anti-VEGF treatment improves neurological function in tumors of the nervous systemNa Zhang, Jie Chen, Gino B Ferraro, et al.
Pageof 21